Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2009 2
2010 2
2012 3
2013 2
2014 3
2015 2
2016 4
2017 7
2018 13
2019 12
2020 6
2021 2
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Treatment strategy of EGFR-mutated non-small cell lung cancer.
Tanaka F, Yoneda K, Takenaka M, Kuroda K. Tanaka F, et al. Among authors: yoneda k. J Thorac Dis. 2022 Mar;14(3):602-606. doi: 10.21037/jtd-22-177. J Thorac Dis. 2022. PMID: 35399242 Free PMC article. No abstract available.
A liquid biopsy in primary lung cancer.
Yoneda K, Imanishi N, Ichiki Y, Tanaka F. Yoneda K, et al. Surg Today. 2019 Jan;49(1):1-14. doi: 10.1007/s00595-018-1659-2. Epub 2018 Apr 11. Surg Today. 2019. PMID: 29644440 Review.
Podoplanin: An emerging cancer biomarker and therapeutic target.
Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, Jensen L, Chalise L, Natsume A, Goldberg GS. Krishnan H, et al. Among authors: yoneda k. Cancer Sci. 2018 May;109(5):1292-1299. doi: 10.1111/cas.13580. Cancer Sci. 2018. PMID: 29575529 Free PMC article. Review.
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses.
Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, Goto A, Honda T, Shimizu K, Torasawa M, Takayanagi D, Saito M, Saito A, Ohe Y, Watanabe SI, Goto K, Tsuboi M, Tsuchihara K, Takata S, Aoi T, Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Maeda D, Yamaura T, Matsuda M, Shimada Y, Mizuno T, Sakamoto H, Yoshida T, Goto Y, Yoshida T, Yamaji T, Sonobe M, Toyooka S, Yoneda K, Masago K, Tanaka F, Hara M, Fuse N, Nishizuka SS, Motoi N, Sawada N, Nishida Y, Kumada K, Takeuchi K, Tanno K, Yatabe Y, Sunami K, Hishida T, Miyazaki Y, Ito H, Amemiya M, Totsuka H, Nakayama H, Yokose T, Ishigaki K, Nagashima T, Ohtaki Y, Imai K, Takasawa K, Minamiya Y, Kobayashi K, Okubo K, Wakai K, Shimizu A, Yamamoto M, Iwasaki M, Matsuda K, Inazawa J, Shiraishi Y, Nishikawa H, Murakami Y, Kubo M, Matsuda F, Kamatani Y, Hamamoto R, Matsuo K, Kohno T. Shiraishi K, et al. Among authors: yoneda k. Cancer Commun (Lond). 2024 Feb;44(2):287-293. doi: 10.1002/cac2.12498. Epub 2023 Oct 26. Cancer Commun (Lond). 2024. PMID: 37882647 Free PMC article. No abstract available.
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
Katayama Y, Yamada T, Tanimura K, Tokuda S, Morimoto K, Hirai S, Matsui Y, Nakamura R, Ishida M, Kawachi H, Yoneda K, Hosoya K, Tsuji T, Ozasa H, Yoshimura A, Iwasaku M, Kim YH, Horinaka M, Sakai T, Utsumi T, Shiotsu S, Takeda T, Katayama R, Takayama K. Katayama Y, et al. Among authors: yoneda k. NPJ Precis Oncol. 2023 Jan 26;7(1):12. doi: 10.1038/s41698-023-00350-7. NPJ Precis Oncol. 2023. PMID: 36702855 Free PMC article.
Recent topics of lung neuroendocrine tumors.
Ichiki Y, Matsumiya H, Mori M, Kanayama M, Nabe Y, Taira A, Shinohara S, Goto H, Kuwata T, Takenaka M, Oka S, Chikaishi Y, Fukuyama T, Imanishi N, Yoneda K, Kuroda K, Kobayashi N, Nakanishi K, Tanaka F. Ichiki Y, et al. Among authors: yoneda k. J Thorac Dis. 2019 Aug;11(8):E133-E134. doi: 10.21037/jtd.2019.08.40. J Thorac Dis. 2019. PMID: 31559084 Free PMC article. No abstract available.
57 results